📰 Insight Reports News
Page 2 - Insight Reports News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Insight Reports. Real-time updates on events, politics, business and more.
October 10, 2023
Incorporating RNA sequencing provides better diagnostics to enable a more complete understanding of disease biology...
September 11, 2023
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...
September 7, 2023
Strong Revenues and Steady Growth in Both Diagnostics and Pharma Segments Drive Sustainable Financial PerformanceFirst half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth...
September 7, 2023
First half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth Pharma and Diagnostics segments deliver strong performance, reaffirming full year 2023 guidance for total revenue growth between 10%
September 1, 2023
Results from pivotal study published in Diagnostics journalConfirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher diseaseCould predict clinical course of patients and improve personalized care CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2023 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced data c...
September 1, 2023
Results from pivotal study published in Diagnostics journalConfirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher...
August 31, 2023
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Aug. 31, 2023 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...
August 18, 2023
CENTOGENE Announces Change in Supervisory Board CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, August 18, 2023 - CENTOGENE N.V. , the essential life science partner for...
August 7, 2023
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Aug. 07, 2023 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...
July 14, 2023
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 14, 2023 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...